Form D Explorer

Form C/A — Eliaz Therapeutics, Inc.

0001670254-25-000712 · filed 2025-07-22 · via Wefunder Portal LLC

Offering

Target: $50,000
Maximum: $3,000,000
Security type: Other
Price per security: $1.0000
Deadline: —
Oversubscription: Accepted

Issuer

Name: Eliaz Therapeutics, Inc.
CIK: 2042609
Entity: Corporation
Jurisdiction: DE
Address: 398 Tesconi Court
Santa Rosa, CA 95401
Phone: —

Most recent fiscal year financials

Total assets

$738,015

Cash

—

Short-term debt

$2,046,085

Long-term debt

$4,188,186

Revenues

—

COGS

—

Taxes paid

—

Net income

$-954,869

View original on SEC EDGAR.